Phospholipids

Abstract Lipid-based drug delivery carriers have exhibited substantial potential for promoting wound healing. Here, Phospholipon® 90H (P90H) based lipid nanoparticles...

Abstract During the pandemic, lipid nanoparticles (LNPs) became widely established as RNA nanocarriers, and hold the promise of future targeting...

Abstract Effective buccal drug delivery is limited by the barrier properties of the mucosa, necessitating innovative systems to enhance permeability...

Abstract This study investigates the influence of phospholipid saturation by comparing hydrogenated soy phosphatidylcholine (HSPC) and egg yolk phosphatidylcholine (EPC)...

Abstract Hybrid lipid nanocapsules (hLNCs) represent a promising platform for mRNA delivery with the added benefit of ambient-temperature stabilization. Conventional...

Abstract Liver diseases—encompassing hepatitis, liver fibrosis, fatty liver, and hepatocellular carcinoma—constitute a formidable global health challenge. Existing treatments are often...

Abstract mRNA delivered by microneedle patch (MNP) can enable painless delivery, reduced need for healthcare expertise, and improved thermostability. In...

Abstract Proteolysis targeting chimeras (PROTACs) are heterobifunctional degraders with a unique mode of action that permits access to “undruggable” targets....

Abstract Nanoparticle carriers can selectively deliver the drug cargo to tumor cells, thus having the ability to prevent early drug...

Abstract The development of solid dispersions (SDs) has gained increased attention in recent decades, leading to successful delivery systems for...